Additional manufacturer narrative: (b)(4) is submitting on behalf of the foreign manufacturer, tosoh corporation, per exemption number (b)(4).This report is being submitted due to a retrospective review conducted under capa (b)(4).Device by manufacturer: on (b)(6) 2016, an fse was dispatched to the customer facility to address the reported event.Fse began to troubleshoot the issue.Fse cleaned out obstruction on injector valve port #3 to correct issue.Fse also cleaned and lubed large syringe worm screw.Customer then ran 20 plus patients with no problems.The customer ran quality control (qc) in which all results were within acceptable range and verified that the analyzer was functioning correctly.The g7 analyzer was functioning as intended and the errors cleared.No further action required by field service.The most probable cause of the reported event was due to a clog in port #3.
|
On (b)(6) 2016, a customer reported a 706 l (large) syringe error with their g7 analyzer.The customer had already replaced the sample needle, performed a sample reset - needle moves smoothly.Customer cleaned the sample drive gear.The g7 sampled one quality control sample then the error returned.The customer is unable to run hba1c patient samples.A field service engineer (fse) was dispatched to address the reported event, which resulted in delayed reporting hba1c patient results.There was no indication of patient intervention or adverse health consequences due to the delay in reporting.
|